Bronchitis study probes hidden world of children's airway germs
NCT ID NCT07255430
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 160 children with protracted bacterial bronchitis (PBB), a condition causing long-term cough. Researchers will analyze samples from the children's airways to understand the mix of bacteria and viruses, how the immune system responds, and how the standard antibiotic treatment (azithromycin) affects these factors. The goal is to learn more about the disease and improve future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- azithromycin
- What this could lead to
- If successful, this could help doctors understand why some children get persistent bronchitis and how standard treatment affects their airway germs and immune system.
- What could go wrong
- This is an observational study with no new treatment being tested. It is early-stage research that may not lead to direct changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROTRACTED BACTERIAL BRONCHITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Antwerp University Hospital
RECRUITINGEdegem, 2650, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.